{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:54:23Z","timestamp":1781506463324,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031022","name":"HHS | NIH | NCI | Center for Cancer Research","doi-asserted-by":"publisher","award":["R35CA241894"],"award-info":[{"award-number":["R35CA241894"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG061350"],"award-info":[{"award-number":["R01AG061350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG061350"],"award-info":[{"award-number":["R01AG061350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R35CA241894"],"award-info":[{"award-number":["R35CA241894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA55349"],"award-info":[{"award-number":["RO1 CA55349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 CA23766"],"award-info":[{"award-number":["PO1 CA23766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG080684"],"award-info":[{"award-number":["R01AG080684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 grants GM115327 & GM136640"],"award-info":[{"award-number":["T32 grants GM115327 & GM136640"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Sunshine Fund"},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["Grant P30 CA008748"],"award-info":[{"award-number":["Grant P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["Experimental Therapeutics Center of MSKCC"],"award-info":[{"award-number":["Experimental Therapeutics Center of MSKCC"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research"},{"name":"William Randolph Hearst Fund in Experimental Therapeutics"},{"DOI":"10.13039\/100023581","name":"NSF | National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["1746886"],"award-info":[{"award-number":["1746886"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"The JPB Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The systemic administration of therapeutic agents, particularly large, charged molecules such as antibodies, has limited efficacy in treating central nervous system (CNS) disorders. In addition, the slow progression of neurodegenerative diseases makes repeated intrathecal injections unfeasible. Alzheimer\u2019s disease is characterized by the accumulation of A\u03b2 amyloid plaques. Microglia contribute to the clearance of A\u03b2, but are inhibited by the expression of CD33. Therefore, antibody blocking of CD33 may enhance the phagocytosis of A\u03b2 by microglial cells, slowing AD progression. Here, we use cells as \u201ctargeted cellular micropharmacies\u201d that are retained in the CNS to deliver therapeutic proteins directly into the brain. To achieve this, we genetically engineered CD4 T-cells to express: (1) a chimeric antigen receptor against GD2 to retain the cells in the brain, (2) ectopic FoxP3 to reduce inflammation, (3) secreted IL-2 to promote cell longevity, and (4) secreted anti-CD33 scFv antibody. Our proof-of-concept demonstrates that therapeutic antibodies can be delivered to the brain for at least 8 weeks to treat neurological disorders. Other agents could be similarly delivered into the brain by this platform.<\/jats:p>","DOI":"10.1038\/s44321-026-00421-9","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:22:10Z","timestamp":1776176530000},"page":"2455-2482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted cellular micropharmacies deliver therapeutic agents to the brain"],"prefix":"10.1038","volume":"18","author":[{"given":"Manish","family":"Malviya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2028-477X","authenticated-orcid":false,"given":"Subha","family":"Baniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1327-2668","authenticated-orcid":false,"given":"Tanya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branavan","family":"Manoranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen C","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Kehs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro C","family":"Silberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-6283","authenticated-orcid":false,"given":"Tao","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-3730","authenticated-orcid":false,"given":"Yueming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0651-7389","authenticated-orcid":false,"given":"David A","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"421_CR1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BMM, Hooli B, DiVito J, Ionita I et al (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83:623\u2013632","journal-title":"Am J Hum Genet"},{"key":"421_CR2","doi-asserted-by":"crossref","first-page":"e160674","DOI":"10.1172\/jci.insight.160674","volume":"7","author":"S Bolivar-Wagers","year":"2022","unstructured":"Bolivar-Wagers S, Loschi ML, Jin S, Thangavelu G, Larson JH, McDonald-Hyman CS, Aguilar EA, Saha A, Koehn BH, Hefazi M et al (2022) Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses. JCI Insight 7:e160674","journal-title":"JCI Insight"},{"key":"421_CR3","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.3390\/ijms23126507","volume":"23","author":"F Borgia","year":"2022","unstructured":"Borgia F, Custurone P, Li Pomi FL, Cordiano R, Alessandrello C, Gangemi S (2022) IL-31: state of the art for an inflammation-oriented interleukin. Int J Mol Sci 23:6507","journal-title":"Int J Mol Sci"},{"key":"421_CR4","doi-asserted-by":"crossref","first-page":"900139","DOI":"10.3389\/fimmu.2022.900139","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Huang W, Xue Y, Chen Y, Qian W, Ma J, August A, Wang J, Zheng SG, Lin J (2022) Neuropilin-1 identifies a new subpopulation of TGF-\u03b2-induced Foxp3+ regulatory T cells with potent suppressive function and enhanced stability during inflammation. Front Immunol 13:900139","journal-title":"Front Immunol"},{"key":"421_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4049\/jimmunol.148.4.1149","volume":"148","author":"MS Co","year":"1992","unstructured":"Co MS, Avdalovic NM, Caron PC, Avdalovic MV, Scheinberg DA, Queen C (1992) Chimeric and humanized antibodies with specificity for the CD33 antigen. J Immunol 148:1149\u20131154","journal-title":"J Immunol"},{"key":"421_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61737-979-6_2","volume":"707","author":"LW Collison","year":"2011","unstructured":"Collison LW, Vignali DAA (2011) In vitro treg suppression assays. Methods Mol Biol 707:21","journal-title":"Methods Mol Biol"},{"key":"421_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/bloodadvances.2022008525","volume":"7","author":"MR Cook","year":"2023","unstructured":"Cook MR, Dorris CS, Makambi KH, Luo Y, Munshi PN, Donato M, Rowley S, Saad A, Goy A, Dunleavy K et al (2023) Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients. Blood Adv 7:32\u201339","journal-title":"Blood Adv"},{"key":"421_CR8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.2022016101","volume":"141","author":"MM Dacek","year":"2023","unstructured":"Dacek MM, Kurtz KG, Wallisch P, Pierre SA, Khayat S, Bourne CM, Gardner TJ, Vogt KC, Aquino N, Younes A et al (2023) Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRP\u03b1 checkpoint blocker. Blood 141:2003\u20132015","journal-title":"Blood"},{"key":"421_CR9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/genes13040693","volume":"13","author":"L Duan","year":"2022","unstructured":"Duan L, Liu X, Luo Z, Zhang C, Wu C, Mu W, Zuo Z, Pei X, Shao T (2022) G-protein subunit gamma 4 as a potential biomarker for predicting the response of chemotherapy and immunotherapy in bladder cancer. Genes 13:693","journal-title":"Genes"},{"key":"421_CR10","doi-asserted-by":"crossref","unstructured":"Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV et al (2023) Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol 16:111","DOI":"10.1186\/s13045-023-01508-3"},{"key":"421_CR11","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00734-8","volume":"19","author":"G Eskandari-Sedighi","year":"2024","unstructured":"Eskandari-Sedighi G, Crichton M, Zia S, Gomez-Cardona E, Cortez LM, Patel ZH, Takahashi-Yamashiro K, St. Laurent CD, Sidhu G, Sarkar S et al (2024) Alzheimer\u2019s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice. Mol Neurodegeneration 19:42","journal-title":"Mol Neurodegeneration"},{"key":"421_CR74","doi-asserted-by":"crossref","unstructured":"Fattorelli N, Martinez-Muriana A, Wolfs L, Geric I, De Strooper B, Mancuso R (2021) Stem-cell-derived human microglia transplanted into mouse brain to study human disease. Nature Protocols 16:1013\u20131033","DOI":"10.1038\/s41596-020-00447-4"},{"key":"421_CR12","doi-asserted-by":"crossref","unstructured":"Fransson M, Piras E, Burman J, Nilsson B, Essand M, Lu BF, Harris RA, Magnusson PU, Brittebo E, Loskog ASI (2012) CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J Neuroinflammation 9:112","DOI":"10.1186\/1742-2094-9-112"},{"key":"421_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12082175","volume":"12","author":"TJ Gardner","year":"2020","unstructured":"Gardner TJ, Bourne CM, Dacek MM, Kurtz K, Malviya M, Peraro L, Silberman PC, Vogt KC, Unti MJ, Brentjens R et al (2020) Targeted cellular micropharmacies: cells engineered for localized drug delivery. Cancers 12:1\u201330","journal-title":"Cancers"},{"key":"421_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41589-021-00932-1","volume":"18","author":"TJ Gardner","year":"2022","unstructured":"Gardner TJ, Lee JP, Bourne CM, Wijewarnasuriya D, Kinarivala N, Kurtz KG, Corless BC, Dacek MM, Chang AY, Mo G et al (2022a) Engineering CAR-T cells to activate small-molecule drugs in situ. Nat Chem Biol 18:216\u2013225","journal-title":"Nat Chem Biol"},{"key":"421_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41589-021-00932-1","volume":"18","author":"TJ Gardner","year":"2022","unstructured":"Gardner TJ, Lee JP, Bourne CM, Wijewarnasuriya D, Kinarivala N, Kurtz KG, Corless BC, Dacek MM, Chang AY, Mo G et al (2022b) Engineering CAR-T cells to activate small-molecule drugs in situ. Nat Chem Biol 18:216\u2013225","journal-title":"Nat Chem Biol"},{"key":"421_CR16","doi-asserted-by":"crossref","first-page":"937133","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel P, Chakrabarti S, Goel K, Bhutani K, Chopra T, Bali S (2022) Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight. Front Mol Neurosci 15:937133","journal-title":"Front Mol Neurosci"},{"key":"421_CR17","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","volume":"29","author":"A Griciuc","year":"2020","unstructured":"Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, Leroy S, Gandhi S, Lerner EP et al (2020) Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet 29:2920\u20132935","journal-title":"Hum Mol Genet"},{"key":"421_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631\u2013643","journal-title":"Neuron"},{"key":"421_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127","journal-title":"N Engl J Med"},{"key":"421_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41593-020-00796-z","volume":"24","author":"SR Guttikonda","year":"2021","unstructured":"Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, Ciceri G, Sneeboer M, Mazutis L, Setty M et al (2021) Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease. Nat Neurosci 24:343\u2013354","journal-title":"Nat Neurosci"},{"key":"421_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/cei\/uxac105","volume":"211","author":"F Harris","year":"2023","unstructured":"Harris F, Berdugo YA, Tree T (2023) IL-2-based approaches to Treg enhancement. Clin Exp Immunol 211:149\u2013163","journal-title":"Clin Exp Immunol"},{"key":"421_CR22","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jid.2021.12.021","volume":"142","author":"S Haskamp","year":"2022","unstructured":"Haskamp S, Frey B, Becker I, Schulz-Kuhnt A, Atreya I, Berking C, Pauli D, Ekici AB, Berges J, M\u00f6\u00dfner R et al (2022) Transcriptomes of MPO-deficient patients with generalized pustular psoriasis reveals expansion of CD4+ cytotoxic T cells and an involvement of the complement system. J Invest Dermatol 142:2149\u20132158.e10","journal-title":"J Invest Dermatol"},{"key":"421_CR23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2019.00274","volume":"10","author":"RW Herzog","year":"2019","unstructured":"Herzog RW, Kuteyeva V, Saboungi R, Terhorst C, Biswas M (2019) Reprogrammed CD4+ T cells that express FoxP3+ control inhibitory antibody formation in hemophilia A mice. Front Immunol 10:274","journal-title":"Front Immunol"},{"key":"421_CR24","doi-asserted-by":"crossref","first-page":"e166028","DOI":"10.1172\/JCI166028","volume":"133","author":"JE Jaspers","year":"2023","unstructured":"Jaspers JE, Khan JF, Godfrey WD, Lopez AV, Ciampricotti M, Rudin CM, Brentjens RJ (2023) IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models. J Clin Invest 133:e166028","journal-title":"J Clin Invest"},{"key":"421_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368:107\u2013116","journal-title":"N Engl J Med"},{"key":"421_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00401-023-02616-7","volume":"146","author":"JM Judd","year":"2023","unstructured":"Judd JM, Jasbi P, Winslow W, Serrano GE, Beach TG, Klein-Seetharaman J, Velazquez R (2023) Inflammation and the pathological progression of Alzheimer\u2019s disease are associated with low circulating choline levels. Acta Neuropathol 146:565\u2013583","journal-title":"Acta Neuropathol"},{"key":"421_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12987-022-00398-w","volume":"19","author":"U Julku","year":"2022","unstructured":"Julku U, Xiong M, Wik E, Roshanbin S, Sehlin D, Syv\u00e4nen S (2022) Brain pharmacokinetics of mono- and bispecific amyloid-\u03b2 antibodies in wild-type and Alzheimer\u2019s disease mice measured by high cut-off microdialysis. Fluids Barriers CNS 19:99","journal-title":"Fluids Barriers CNS"},{"key":"421_CR28","doi-asserted-by":"crossref","first-page":"eaay1359","DOI":"10.1126\/scitranslmed.aay1359","volume":"12","author":"MS Kariolis","year":"2020","unstructured":"Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, Kim DJ, Srivastava A, Bedard C, Henne KR et al (2020) Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med 12:eaay1359","journal-title":"Sci Transl Med"},{"key":"421_CR29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tig.2017.08.008","volume":"33","author":"P Kebriaei","year":"2017","unstructured":"Kebriaei P, Izsv\u00e1k Z, Narayanavari SA, Singh H, Ivics Z (2017) Gene therapy with the sleeping beauty transposon system. Trends Genet 33:852\u2013870","journal-title":"Trends Genet"},{"key":"421_CR30","doi-asserted-by":"crossref","first-page":"e20192195","DOI":"10.1084\/jem.20192195","volume":"217","author":"ME Keir","year":"2020","unstructured":"Keir ME, Yi T, Lu TT, Ghilardi N (2020) The role of IL-22 in intestinal health and disease. J Exp Med 217:e20192195","journal-title":"J Exp Med"},{"key":"421_CR31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.168.2.597","volume":"168","author":"E Kelly","year":"2002","unstructured":"Kelly E, Won A, Refaeli Y, Van Parijs L (2002) IL-2 and related cytokines can promote T cell survival by activating AKT. J Immunol 168:597\u2013603","journal-title":"J Immunol"},{"key":"421_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TAW, Chan S et al (2015) Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350:334\u2013339","journal-title":"Science"},{"key":"421_CR33","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.3390\/ijms22126442","volume":"22","author":"A Kouhi","year":"2021","unstructured":"Kouhi A, Pachipulusu V, Kapenstein T, Hu P, Epstein AL, Khawli LA (2021) Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives. Int J Mol Sci 22:6442","journal-title":"Int J Mol Sci"},{"key":"421_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1120","volume":"1","author":"A Kriz","year":"2010","unstructured":"Kriz A, Schmid K, Baumgartner N, Ziegler U, Berger I, Ballmer-Hofer K, Berger P (2010) A plasmid-based multigene expression system for mammalian cells. Nat Commun 1:120","journal-title":"Nat Commun"},{"key":"421_CR35","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.7150\/thno.87489","volume":"13","author":"K Kurtz","year":"2023","unstructured":"Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C et al (2023) Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications. Theranostics 13:5469\u20135482","journal-title":"Theranostics"},{"key":"421_CR36","first-page":"909","volume":"3","author":"GA Lammie","year":"1993","unstructured":"Lammie GA, Cheung NKV, Gerald W, Rosenblum M, Cordon-Cardo C (1993) Ganglioside GD(2) expression in the human nervous-system and in neuroblastomas\u2014an immunohistochemical study. Int J Oncol 3:909\u2013915","journal-title":"Int J Oncol"},{"key":"421_CR37","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/alz.12610","volume":"18","author":"D Lecca","year":"2022","unstructured":"Lecca D, Jung YJ, Scerba MT, Hwang I, Kim YK, Kim S, Modrow S, Tweedie D, Hsueh SC, Liu D et al (2022) Role of chronic neuroinflammation in neuroplasticity and cognitive function: a hypothesis. Alzheimers Dement 18:2327\u20132340","journal-title":"Alzheimers Dement"},{"key":"421_CR38","doi-asserted-by":"crossref","first-page":"618110","DOI":"10.3389\/fimmu.2021.618110","volume":"12","author":"H Lindahl","year":"2021","unstructured":"Lindahl H, Olsson T (2021) Interleukin-22 influences the Th1\/Th17 axis. Front Immunol 12:618110","journal-title":"Front Immunol"},{"key":"421_CR39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2144\/btn-2020-0003","volume":"68","author":"B Lindner","year":"2020","unstructured":"Lindner B, Burkard T, Schuler M (2020) Phagocytosis assays with different pH-sensitive fluorescent particles and various readouts. Biotechniques 68:245\u2013250","journal-title":"Biotechniques"},{"key":"421_CR40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nm.3485","volume":"20","author":"Y Liu","year":"2014","unstructured":"Liu Y, Carlsson R, Comabella M, Wang JY, Kosicki M, Carrion B, Hasan M, Wu X, Montalban X, Dziegiel MH et al (2014) FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nat Med 20:272\u2013282","journal-title":"Nat Med"},{"key":"421_CR41","doi-asserted-by":"crossref","first-page":"n1462","DOI":"10.1136\/bmj.n1462","volume":"373","author":"E Mahase","year":"2021","unstructured":"Mahase E (2021) FDA approves controversial Alzheimer\u2019s drug despite uncertainty over effectiveness. BMJ 373:n1462","journal-title":"BMJ"},{"key":"421_CR42","doi-asserted-by":"crossref","first-page":"102401","DOI":"10.1016\/j.jaut.2020.102401","volume":"108","author":"M Malviya","year":"2020","unstructured":"Malviya M, Saoudi A, Bauer J, Fillatreau S, Liblau R (2020) Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells. J Autoimmun 108:102401","journal-title":"J Autoimmun"},{"key":"421_CR43","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40:4288\u20134297","journal-title":"Nucleic Acids Res"},{"key":"421_CR44","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1007\/s00262-023-03529-w","volume":"72","author":"SS Mun","year":"2023","unstructured":"Mun SS, Meyerberg J, Peraro L, Korontsvit T, Gardner T, Malviya M, Kyi C, O\u2019Cearbhaill RE, Liu C, Dao T et al (2023) Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1. Cancer Immunol Immunother 72:3773\u20133786","journal-title":"Cancer Immunol Immunother"},{"key":"421_CR45","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.4049\/jimmunol.2100138","volume":"207","author":"BP Nicolet","year":"2021","unstructured":"Nicolet BP, Guislain A, Wolkers MC (2021) CD29 enriches for cytotoxic human CD4+ T cells. J Immunol 207:2966\u20132975","journal-title":"J Immunol"},{"key":"421_CR46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/acssynbio.0c00643","volume":"10","author":"YD Patel","year":"2021","unstructured":"Patel YD, Brown AJ, Zhu J, Rosignoli G, Gibson SJ, Hatton D, James DC (2021) Control of multigene expression stoichiometry in mammalian cells using synthetic promoters. ACS Synth Biol 10:1155\u20131165","journal-title":"ACS Synth Biol"},{"key":"421_CR47","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.ymthe.2021.06.022","volume":"29","author":"L Peraro","year":"2021","unstructured":"Peraro L, Bourne CM, Dacek MM, Akalin E, Park JH, Smith EL, Scheinberg DA (2021) Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection. Mol Ther 29:3398\u20133409","journal-title":"Mol Ther"},{"key":"421_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/vim.2018.0084","volume":"32","author":"S Prasad","year":"2019","unstructured":"Prasad S, Lokensgard JR (2019) Brain-resident T cells following viral infection. Viral Immunol 32:48","journal-title":"Viral Immunol"},{"key":"421_CR49","doi-asserted-by":"crossref","unstructured":"Qiao Y, Sun Q, Chen X, Wang D, Su R, Xue Y, Sun H, Wang H (2023) Nuclear m6A reader YTHDC1 promotes muscle stem cell activation\/proliferation by regulating mRNA splicing and nuclear export. eLife 12:e82703","DOI":"10.7554\/eLife.82703"},{"key":"421_CR50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/2326-6066.CIR-17-0211","volume":"6","author":"SA Richman","year":"2018","unstructured":"Richman SA, Nunez-Cruz S, Moghimi B, Li LZ, Gershenson ZT, Mourelatos Z, Barrett DM, Grupp SA, Milone MC (2018) High-affinity GD2-specific CAR T cells induce fatal encephalitis in a preclinical neuroblastoma model. Cancer Immunol Res 6:36\u201346","journal-title":"Cancer Immunol Res"},{"key":"421_CR51","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","volume":"92","author":"I Rivi\u00e8re","year":"1995","unstructured":"Rivi\u00e8re I, Brose K, Mulligan RC (1995) Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733","journal-title":"Proc Natl Acad Sci USA"},{"key":"421_CR52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139\u2013140","journal-title":"Bioinformatics"},{"key":"421_CR53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky AY (2011) Regulatory T cells and Foxp3. Immunol Rev 241:260\u2013268","journal-title":"Immunol Rev"},{"key":"421_CR54","doi-asserted-by":"crossref","first-page":"e0148474","DOI":"10.1371\/journal.pone.0148474","volume":"11","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Eriksson M, Shang MM, Weyd H, Tegn\u00e9r J (2016) Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate. PLoS ONE 11:e0148474","journal-title":"PLoS ONE"},{"key":"421_CR55","doi-asserted-by":"crossref","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2022) Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab. Front Aging Neurosci 14:870517","DOI":"10.3389\/fnagi.2022.870517"},{"key":"421_CR56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1508\/cytologia.84.107","volume":"84","author":"MK Shibuta","year":"2019","unstructured":"Shibuta MK, Matsuoka M, Matsunaga S (2019) 2A peptides contribute to the co-expression of proteins for imaging and genome editing. Cytologia 84:107\u2013111","journal-title":"Cytologia"},{"key":"421_CR57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks JD, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES et al (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA 330:512\u2013527","journal-title":"JAMA"},{"key":"421_CR58","doi-asserted-by":"crossref","unstructured":"Skuljec J, Chmielewski M, Happle C, Habener A, Busse M, Abken H, Hansen G (2017) Chimeric antigen receptor-redirected regulatory T cells suppress experimental allergic airway inflammation, a model of asthma. Front Immunol 8:1125","DOI":"10.3389\/fimmu.2017.01125"},{"key":"421_CR59","volume":"20","author":"T Su","year":"2025","unstructured":"Su T, Hung W, Cheng IH (2025) The involvement of human CD33 in the pathogenesis of Alzheimer\u2019s disease mouse model. Alzheimer\u2019s Dement 20:e086747","journal-title":"Alzheimer\u2019s Dement"},{"key":"421_CR60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20150519","volume":"213","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi A, Badr MESG, Miyauchi K, Ishihara C, Onishi R, Guo Z, Sasaki Y, Ike H, Takumi A, Tsuji NM et al (2016) CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J Exp Med 213:123\u2013138","journal-title":"J Exp Med"},{"key":"421_CR61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000511506","volume":"49","author":"A Tian Hui Kwan","year":"2020","unstructured":"Tian Hui Kwan A, Arfaie S, Therriault J, Rosa-Neto P, Gauthier S (2020) Lessons learnt from the second generation of anti-amyloid monoclonal antibodies clinical trials. Dement Geriatr Cogn Disord 49:334\u2013348","journal-title":"Dement Geriatr Cogn Disord"},{"key":"421_CR62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acschemneuro.5b00313","volume":"7","author":"JD Ulrich","year":"2016","unstructured":"Ulrich JD, Holtzman DM (2016) TREM2 function in Alzheimer\u2019s disease and neurodegeneration. ACS Chem Neurosci 7:420\u2013427","journal-title":"ACS Chem Neurosci"},{"key":"421_CR63","first-page":"142","volume":"22","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 22:142\u2013143","journal-title":"N Engl J Med"},{"key":"421_CR64","doi-asserted-by":"crossref","first-page":"1144414","DOI":"10.3389\/fneur.2023.1144414","volume":"14","author":"R Velasco","year":"2023","unstructured":"Velasco R, Mussetti A, Villagr\u00e1n-Garc\u00eda M, Sureda A (2023) CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: is it still a concern? Front Neurol 14:1144414","journal-title":"Front Neurol"},{"key":"421_CR65","doi-asserted-by":"crossref","first-page":"17872","DOI":"10.1073\/pnas.1010201107","volume":"107","author":"LM Wakim","year":"2010","unstructured":"Wakim LM, Woodward-Davis A, Bevan MJ (2010) Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci USA 107:17872\u201317879","journal-title":"Proc Natl Acad Sci USA"},{"key":"421_CR66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.2007.00565.x","volume":"220","author":"YY Wan","year":"2007","unstructured":"Wan YY, Flavell RA (2007) \u2018Yin-Yang\u2019 functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 220:199\u2013213","journal-title":"Immunol Rev"},{"key":"421_CR67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH et al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160:1061\u20131071","journal-title":"Cell"},{"key":"421_CR68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/aid.2017.0187","volume":"34","author":"Y Wang","year":"2018","unstructured":"Wang Y, Nag M, Tuohy JL, De Paris K, Fogle JE (2018) T Regulatory cell induced Foxp3 binds the IL2, IFN\u03b3, and TNF\u03b1 promoters in virus-specific CD8+ T cells from feline immunodeficiency virus infected cats. AIDS Res Hum Retroviruses 34:269\u2013276","journal-title":"AIDS Res Hum Retroviruses"},{"key":"421_CR69","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41380-024-02474-z","volume":"29","author":"E Wong","year":"2024","unstructured":"Wong E, Malviya M, Jain T, Liao GP, Kehs Z, Chang JC, Studer L, Scheinberg DA, Li YM (2024) HuM195 and its single-chain variable fragment increase A\u03b2 phagocytosis in microglia via elimination of CD33 inhibitory signaling. Mol Psychiatry 29:2084\u20132094","journal-title":"Mol Psychiatry"},{"key":"421_CR70","doi-asserted-by":"crossref","first-page":"1012968","DOI":"10.3389\/fncel.2022.1012968","volume":"16","author":"T Xiong","year":"2022","unstructured":"Xiong T, Wang X, Zha Y, Wang Y (2022) Interleukin-33 regulates the functional state of microglia. Front Cell Neurosci 16:1012968","journal-title":"Front Cell Neurosci"},{"key":"421_CR71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","volume":"38","author":"DMW Zaiss","year":"2013","unstructured":"Zaiss DMW, van Loosdregt J, Gorlani A, Bekker CPJ, Gr\u00f6ne A, Sibilia M, van Bergen en Henegouwen PMP, Roovers RC, Coffer PJ, Sijts AJAM (2013) Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 38:275\u2013284","journal-title":"Immunity"},{"key":"421_CR72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248","journal-title":"Signal Transduct Target Ther"},{"key":"421_CR73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000492596","volume":"65","author":"L Zhao","year":"2019","unstructured":"Zhao L (2019) CD33 in Alzheimer\u2019s disease\u2014biology, pathogenesis, and therapeutics: a mini-review. Gerontology 65:323\u2013331","journal-title":"Gerontology"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00421-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:33:00Z","timestamp":1781505180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00421-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,15]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00421-9","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DAS serves on the board of, or has equity in, or income from Lantheus, Sellas, Iovance, Lilly, Actinium Pharmaceuticals, Repertoire, Sapience, Atengen, Epics, Omnipotent, and Eureka Therapeutics. TD is a consultant for Eureka Therapeutics. A patent has been applied for by Memorial Sloan Kettering Cancer Center to protect parts of this work. Manish Malviya is currently employed at Astrazeneca.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}